Funds affiliated with Casdin Capital and director Eli Casdin acquired approximately $11.1 million worth of shares in GeneDx Holdings Corp. (NASDAQ:WGS) across two transactions last week. The purchases, totaling 200,000 shares of Class A Common Stock, took place on June 4 and June 5, with prices ranging from $52.8566 to $56.4449 per share.
The transactions were primarily made by Casdin Partners Master Fund, L.P. The filing indicates that Casdin Capital, LLC, which serves as the investment adviser to the Master Fund, along with Casdin Partners GP, LLC, the general partner of the Master Fund, and Eli Casdin, who is the managing member of both Casdin Capital and the GP, may be deemed indirect beneficial owners of these securities. Eli Casdin is also a director and a ten percent owner of GeneDx Holdings Corp.
The insider purchases come as GeneDx shares have declined 67% over the past six months, with the stock currently trading at $51.75. According to InvestingPro analysis, which tracks 10+ additional tips for WGS, analysts predict the company will be profitable this year despite recent volatility. The $1.55 billion market cap company maintains a